News Center

With the tenet of "Healthy China, Dedicated commitment", Linuo Pharmaceuticals increases cooperation and association with external scientific research institutes while innovating and developing independently.

01

2025

-

12

The first year ushers in a new beginning—returning with honors! Keyuan Pharmaceutical and Linuo Pharmaceutical have won multiple prestigious awards at the Group’s celebration!

Classification:

行业新闻

Corporate News

Staff Style


Recently, the 31st-anniversary gala of Linuo Group was held with great splendor in Jinan. Keyuan Pharmaceutical (stock code: 301281.SZ) and Linuo Pharmaceutical have been reporting frequent good news, winning numerous individual and collective awards in the recognition of meritorious achievements. Moreover, during the cultural and artistic performance, the team showcased its vibrant and uplifting spirit through outstanding performances, achieving a double win of both business results and cultural enrichment.

During the highly anticipated awards ceremony, Outstanding representatives from the management teams, core executives, and frontline employees of Keyuan Pharmaceutical and Linuo Pharmaceutical have all been recognized with prestigious awards. The scope of these awards spans multiple key areas—including management, marketing, production, supply chain, and quality—demonstrating the comprehensiveness and high caliber of the companies’ talent pool. Meanwhile, both companies have jointly received numerous awards for advanced collective achievements. This well-deserved recognition is the highest honor bestowed upon the companies’ overall operations and team collaboration capabilities.

On the stage of honor, their talents were no less impressive. At the subsequent cultural gala, Linuo Pharmaceutical won thunderous applause with their performance titled "Qilin Brings Auspiciousness." Adapted show "Dragon Clan" By weaving the corporate spirit and development blueprint into the lyrics, the passionate singing of Linuo Pharmaceutical’s employees expresses their confidence and bold aspirations. Keyuan Pharmaceutical highlighted its international perspective and precise strategic planning during the celebration. Through a solemn oath, the company conveyed its original commitment to safeguarding health and outlined its vision more clearly. Top 100 in Five Years The development blueprint.

This comprehensive success at the group’s celebration is a microcosm of Kexuan Pharmaceutical and Linuo Pharmaceutical’s outstanding performance over the past year. Filled with honors, as we embark on a new journey, every member of the company will surely take this as a fresh starting point. With a more vigorous spirit and more pragmatic actions, let us forge ahead with determination and create new glories.

Related news

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

Renowned financial writer Wu Xiaobo visited Keyuan Pharmaceutical, praising the company’s achievements in digital and intelligent transformation.

2026-05-18

On May 16–17, Wu Xiaobo, known as “China’s foremost financial writer” and a renowned entrepreneur, led a delegation to visit and inspect Keyuan Pharmaceutical (stock code: 301281.SZ). The group focused on the company’s achievements in integrating smart manufacturing with digital AI technologies in the pharmaceutical sector, engaged in in-depth discussions with its core management team, and expressed high praise for the company’s practical approach to driving industrial upgrading through digital and intelligent transformation. Gao Yuankun, Chairman and President of Linuo Group, along with Li Hongfu, Chairman of Keyuan Pharmaceutical, and Wei Zhiguo, President of the company, accompanied the delegation during the visit.